Facebook Tells Pharma Brands They Must Allow Comments

It was an important and clearly predictable step from Facebook to tell pharma brands that they must allow comments on their Facebook pages. Andrew Spong, Marc Monseau and Alex Butler had quite positive comments about that in a Facebook discussion. We will certainly include this in our open-access guide for pharma companies.

Pharma brand marketers that disable comments on their Facebook pages are in for a change. As predicted, Facebook will no longer allow pharma brands – which are typically highly risk averse when it comes to discussions about their drugs and products in social media environments – to turn off commenting on their pages.

In an effort to keep Facebook a forum for open dialogue, the company will not allow admins of new pages to disable commenting on their pages, according to a company spokesperson. In addition, brands with preexisting pages will be required to allow comments after August 15, according to an email sent by Facebook reps notifying clients of the changes. The email was posted yesterday to the Intouch Soul blog, associated with pharma marketing agency Intouch Solutions.